US President Trump’s Tariff Proposals Acted As Tax On American Consumers, Raising Inflation: Former IMF Chief Economist Gopinath
Slamming Trump’s "Liberation Day" tariffs, IMF Chief Economist Gita Gopinath said the scorecard has been negative for the last six months. Trump proclaimed “Liberation Day” on April 2, when he announced the most sweeping tariff hike.

File Image |
New Delhi: US President Donald Trump’s tariff proposals acted as a tax on US consumers, raised inflation, and had no benefit to the American economy, said former IMF Chief Economist Gita Gopinath on Wednesday. Slamming Trump’s "Liberation Day" tariffs, Gopinath said the scorecard has been negative for the last six months. Trump proclaimed “Liberation Day” on April 2, when he announced the most sweeping tariff hike.
He declared a national emergency over the US trade deficit and invoked the International Emergency Economic Powers Act (IEEPA) to authorise sweeping tariffs on foreign imports. He aimed to correct what he described as decades of unfair trade barriers that had hurt American producers. However, Gopinath stated that in the last six months, the tariffs neither improved the trade balance nor boosted manufacturing in America, as claimed by Trump. It brought no benefit to the US economy.
ALSO READ
In a post on social media platform X, Gopinath said: “It is 6 months since 'Liberation Day' tariffs. What have US tariffs accomplished?” “1. Raise revenue for the government? Yes. Quite substantially. Borne almost entirely by US firms and passed on some to US consumers. So it has worked like a tax on US firms/consumers. 2. Raise inflation? Yes, by small amounts overall. More substantially for household appliances, furniture, coffee. 3. Improve trade balance? No sign yet of that.
4. Improve US manufacturing? No sign yet of that. Overall, the score card is negative,” added the Harvard Economics Professor. India was hit with a 25 per cent tariff in July, followed by an additional 25 per cent penalty on its purchases of Russian crude oil in August. On September 26, Trump further announced plans to impose a 100 per cent tariff on branded and patented pharmaceutical products from October 1 unless companies set up production facilities in the US.
Disclaimer: This story is from the syndicated feed. Nothing has changed except the headline.
RECENT STORIES
-
Indian Coast Guard Recruitment 2025: Registration Process For Group C Posts Underway; Check Details... -
'I Felt Alive': Paralysed Influencer's Emotional Video Of Walking After 10 Years Go Viral | WATCH -
'Gateway To Growth': Netizens Applaud Inauguration Of NMIA, Metro 3 Final Phase, STEP Program &... -
Professor Arrested For Sexually Harassing Undergraduate Student In Bengaluru -
Finland Gives Permanent Residency To Indians: Who Is Eligible To Go & How Can You Apply?